Results 81 to 90 of about 5,034 (114)

Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy. [PDF]

open access: yesRheumatology (Oxford)
Veldkamp SR   +18 more
europepmc   +1 more source

Achieving Medication-Free Remission in Patients With Juvenile Dermatomyositis. [PDF]

open access: yesACR Open Rheumatol
Maccora I   +7 more
europepmc   +1 more source

The Role of Pyroptosis-Related Gene Signature and Immune Infiltration in Juvenile Dermatomyositis. [PDF]

open access: yesClin Cosmet Investig Dermatol
Qiao W   +9 more
europepmc   +1 more source

Thromboembolic Risk in Juvenile Dermatomyositis Patients Treated With Intravenous Immunoglobulin. [PDF]

open access: yesPediatr Dermatol
Gomes LLA   +5 more
europepmc   +1 more source

Muscle Spatial Transcriptomic Reveals Heterogeneous Profiles in Juvenile Dermatomyositis and Persistence of Abnormal Signature After Remission. [PDF]

open access: yesCells
Tragin M   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy